MOHELNIKOVA-DUCHONOVA, Beatrice, Veronika BRYNYCHOVA, Martin OLIVERIUS, Eva HONSOVA, Zdeněk KALA, Katarína MÚČKOVÁ a Pavel SOUCEK. Differences in Transcript Levels of ABC Transporters Between Pancreatic Adenocarcinoma and Nonneoplastic Tissues. Pancreas. USA: Lippincott Williams Wilkins, 2013, roč. 42, č. 4, s. 707-716. ISSN 0885-3177. Dostupné z: https://dx.doi.org/10.1097/MPA.0b013e318279b861.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Differences in Transcript Levels of ABC Transporters Between Pancreatic Adenocarcinoma and Nonneoplastic Tissues
Autoři MOHELNIKOVA-DUCHONOVA, Beatrice (203 Česká republika), Veronika BRYNYCHOVA (203 Česká republika), Martin OLIVERIUS (203 Česká republika), Eva HONSOVA (203 Česká republika), Zdeněk KALA (203 Česká republika, garant, domácí), Katarína MÚČKOVÁ (703 Slovensko, domácí) a Pavel SOUCEK (203 Česká republika).
Vydání Pancreas, USA, Lippincott Williams Wilkins, 2013, 0885-3177.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30200 3.2 Clinical medicine
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.008
Kód RIV RIV/00216224:14110/13:00072145
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1097/MPA.0b013e318279b861
UT WoS 000317655200022
Klíčová slova anglicky pancreas; carcinoma; ABC transporters; expression; KRAS
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 14. 2. 2014 18:44.
Anotace
Objectives: The aim of this study was to evaluate transcript levels of all 49 human ATP-binding cassette transporters (ABCs) in one of the most drug-resistant cancers, namely, the pancreatic ductal adenocarcinoma (PDAC). Association of ABCs levels with clinical-pathologic characteristics and KRAS mutation status was followed as well. Methods: Tumors and adjacent nonneoplastic tissues were obtained from 32 histologically verified PDAC patients. The transcript profile of ABCs was assessed using quantitative real-time polymerase chain reaction with a relative standard curve. KRAS mutations in exon 2 were assessed by high-resolution melting analysis and sequencing. Results: Most ABCs were deregulated in PDAC and 10 ABCs were associated with clinical-pathologic characteristics. KRAS mutations did not change the global expression profile of ABCs. Conclusions: The expression of ABC transporters was significantly deregulated in PDAC tumors when compared to nonmalignant tissues. The observed up-regulation of ABCB4, ABCB11, ABCC1, ABCC3, ABCC5, ABCC10, and ABCG2 in tumors may contribute to the generally poor treatment response of PDAC. The up-regulation of ABCA1, ABCA7, and ABCG1 implicates a serious impairment of cellular cholesterol homeostasis in PDAC. On the other hand, the observed down-regulation of ABCA3, ABCC6, ABCC7, and ABCC8 suggests a possible role of stem cells in the development and progression of PDAC.
VytisknoutZobrazeno: 8. 9. 2024 14:40